Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Net Sales
160.36
169.13
154.70
167.93
182.36
136.89
147.33
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
160.36
169.13
154.70
167.93
182.36
136.89
147.33
Raw Material Cost
100.87
120.75
119.57
98.98
112.46
107.94
107.92
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
39.37
51.07
38.66
40.90
34.75
53.11
34.65
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.96
1.14
1.42
1.09
0.89
0.97
1.06
Selling and Distribution Expenses
15.01
22.57
10.72
16.12
17.28
24.39
9.17
Other Expenses
-4.03
-5.22
-4.01
-4.20
-3.56
-5.41
-3.57
Total Expenditure (Excl Depreciation)
115.88
143.32
130.29
115.10
129.74
132.33
117.09
Operating Profit (PBDIT) excl Other Income
44.5
25.8
24.4
52.800000000000004
52.599999999999994
4.6000000000000005
30.2
Other Income
-0.03
0.93
-1.42
2.35
0.32
-0.28
-0.42
Operating Profit (PBDIT)
49.14
24.03
26.65
51.48
50.55
12.06
24.28
Interest
0.96
1.14
1.42
1.09
0.89
0.97
1.06
Exceptional Items
0.00
0.00
0.00
0.00
0.00
-0.90
0.00
Gross Profit (PBDT)
59.50
48.38
35.13
68.95
69.90
28.95
39.41
Depreciation
12.84
11.97
11.47
11.08
10.54
7.36
7.10
Profit Before Tax
35.34
10.92
13.76
39.31
39.12
2.84
16.11
Tax
2.70
-3.34
0.02
2.43
1.81
-1.52
1.38
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
32.64
14.27
13.74
36.88
37.31
4.36
14.73
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
32.64
14.27
13.74
36.88
37.31
4.36
14.73
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
32.64
14.27
13.74
36.88
37.31
4.36
14.73
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.1
0.1
0.1
0.1
0.1
0.1
0.1
Reserves
926.95
894.31
879.23
865.49
884.28
846.96
727.92
Earnings per share (EPS)
0.05
0.02
0.02
0.05
0.06
0.01
0.02
Diluted Earnings per share
0.05
0.02
0.02
0.05
0.06
0.01
0.02
Operating Profit Margin (Excl OI)
22.66%
6.58%
10.73%
22.66%
21.77%
3.63%
11.95%
Gross Profit Margin
30.05%
13.53%
16.31%
30.0%
27.24%
7.45%
15.75%
PAT Margin
20.36%
8.43%
8.88%
21.96%
20.46%
3.18%
10.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2025 is -5.14% vs 9.31% in Dec 2024
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2025 is 127.97% vs 4.38% in Dec 2024
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2025 is 112.99% vs -17.79% in Dec 2024
Interest
QoQ Growth in quarter ended Mar 2025 is -9.09% vs -21.43% in Dec 2024
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2025 has improved from Dec 2024
Compare Quarterly Results Of Antibiotice SA With
Figures in Million
Consolidate Quarterly Results
Change(RON)
Change(%)
Net Sales
160.36
95.08
65.28
68.66%
Other Operating Income
0.00
0.00
0.00
Total Operating income
160.36
95.08
65.28
68.66%
Raw Material Cost
100.87
37.77
63.10
167.06%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
39.37
13.86
25.51
184.05%
Power Cost
0
0
0.00
Manufacturing Expenses
0.96
0.00
0.96
Selling and Distribution Expenses
15.01
19.49
-4.48
-22.99%
Other Expenses
-4.03
-1.39
-2.64
-189.93%
Total Expenditure (Excl Depreciation)
115.88
57.27
58.61
102.34%
Operating Profit (PBDIT) excl Other Income
44.48
37.81
6.67
17.64%
Other Income
-0.03
1.08
-1.11
-102.78%
Operating Profit (PBDIT)
49.14
42.23
6.91
16.36%
Interest
0.96
0.00
0.96
Exceptional Items
0.00
-0.04
0.04
100.00%
Gross Profit (PBDT)
59.50
57.31
2.19
3.82%
Depreciation
12.84
4.27
8.57
200.70%
Profit Before Tax
35.34
37.91
-2.57
-6.78%
Tax
2.70
5.59
-2.89
-51.70%
Provisions and contingencies
0
0
0.00
Profit After Tax
32.64
32.33
0.31
0.96%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
32.64
32.33
0.31
0.96%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
32.64
32.33
0.31
0.96%
Equity Capital
0
0
0.00
Face Value
0.10
0.10
0.00
Reserves
926.95
510.59
416.36
81.54%
Earnings per share (EPS)
0.05
0.00
0.05
Diluted Earnings per share
0.05
0.00
0.05
Operating Profit Margin (Excl OI)
22.66%
38.79%
0.00
-16.13%
Gross Profit Margin
30.05%
44.37%
0.00
-14.32%
PAT Margin
20.36%
34.00%
0.00
-13.64%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 16.04 Million
in Mar 2025Figures in Million
QoQ Growth in quarter ended Mar 2025 is -5.14% vs 9.31% in Dec 2024
YoY Growth in quarter ended Mar 2025 is -12.06% vs 2.07% in Mar 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.26 Million
in Mar 2025Figures in Million
QoQ Growth in quarter ended Mar 2025 is 127.97% vs 4.38% in Dec 2024
YoY Growth in quarter ended Mar 2025 is -12.60% vs 68.02% in Mar 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.92 Million
in Mar 2025Figures in Million
QoQ Growth in quarter ended Mar 2025 is 112.99% vs -17.79% in Dec 2024
YoY Growth in quarter ended Mar 2025 is -1.99% vs 43.84% in Mar 2024
Quarterly - Interest
Interest 0.10 Million
in Mar 2025Figures in Million
QoQ Growth in quarter ended Mar 2025 is -9.09% vs -21.43% in Dec 2024
YoY Growth in quarter ended Mar 2025 is 11.11% vs -10.00% in Mar 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.66%
in Mar 2025Figures in %
QoQ Growth in quarter ended Mar 2025 has improved from Dec 2024
YoY Growth in quarter ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
